These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 33271653)
1. [Usefulness of Fluorescent Urine Cytology in the Diagnosis of Urothelial Carcinoma]. Yamamichi G; Nakata W; Yoshimura A; Tsujimura G; Tsujimoto Y; Nin M; Mimura A; Miwa H; Tsujihata M Hinyokika Kiyo; 2020 Nov; 66(11):377-381. PubMed ID: 33271653 [TBL] [Abstract][Full Text] [Related]
2. High diagnostic efficacy of 5-aminolevulinic acid-induced fluorescent urine cytology for urothelial carcinoma. Yamamichi G; Nakata W; Tani M; Tsujimura G; Tsujimoto Y; Nin M; Mimura A; Miwa H; Tsujihata M Int J Clin Oncol; 2019 Sep; 24(9):1075-1080. PubMed ID: 30976938 [TBL] [Abstract][Full Text] [Related]
3. High performance of 5-aminolevulinic acid-induced fluorescent selective upper tract urinary cytology. Yamamichi G; Nakata W; Yoshimura A; Tsujimura G; Tsujimoto Y; Nin M; Mimura A; Miwa H; Tsujihata M Int J Urol; 2020 Mar; 27(3):213-218. PubMed ID: 31916332 [TBL] [Abstract][Full Text] [Related]
4. Cytokeratin 20 immunocytochemistry on urine sediments: A potential low-cost adjunct to cytology in the diagnosis of low-grade urothelial carcinoma. Wadhwa N; Diwaker P; Lotha N; Arora VK; Singh N Cytopathology; 2017 Dec; 28(6):531-535. PubMed ID: 28940433 [TBL] [Abstract][Full Text] [Related]
5. Ureterorenoscopic biopsy and urinary cytology according to the 2004 WHO classification underestimate tumor grading in upper urinary tract urothelial carcinoma. Straub J; Strittmatter F; Karl A; Stief CG; Tritschler S Urol Oncol; 2013 Oct; 31(7):1166-70. PubMed ID: 22300757 [TBL] [Abstract][Full Text] [Related]
6. The use of urinary nuclear matrix protein 22 (NMP22) as a diagnostic adjunct to urine cytology for monitoring of recurrent bladder cancer--institutional experience and review. Önal B; Han Ü; Yilmaz S; Köybasioglu F; Altuğ U Diagn Cytopathol; 2015 Apr; 43(4):307-14. PubMed ID: 25488052 [TBL] [Abstract][Full Text] [Related]
7. Urine cytology findings in patients with biopsy-confirmed urothelial carcinoma in situ with plasmacytoid features. Nichols MM; Reynolds JP; McKenney JK; Nicolas MM; McIntire PJ; Policarpio-Nicolas MLC Cancer Cytopathol; 2021 Oct; 129(10):798-804. PubMed ID: 33900681 [TBL] [Abstract][Full Text] [Related]
8. Immunocytochemical staining for p53 and Ki-67 helps to characterise urothelial cells in urine cytology. Courtade-Saïdi M; Aziza J; d'Aure D; Bérard E; Evrard S; Basset C; Lacoste-Collin L Cytopathology; 2016 Dec; 27(6):456-464. PubMed ID: 27873391 [TBL] [Abstract][Full Text] [Related]
9. An institutional experience with The Paris System: A paradigm shift from ambiguous terminology to more objective criteria for reporting urine cytology. Roy M; Kaushal S; Jain D; Seth A; Iyer VK; Mathur SR Cytopathology; 2017 Dec; 28(6):509-515. PubMed ID: 28833848 [TBL] [Abstract][Full Text] [Related]
11. Does subdivision of the "atypical" urine cytology increase predictive accuracy for urothelial carcinoma? Bostwick DG; Hossain D Diagn Cytopathol; 2014 Dec; 42(12):1034-44. PubMed ID: 24838797 [TBL] [Abstract][Full Text] [Related]
12. ROS generation via NOX4 and its utility in the cytological diagnosis of urothelial carcinoma of the urinary bladder. Shimada K; Fujii T; Anai S; Fujimoto K; Konishi N BMC Urol; 2011 Oct; 11():22. PubMed ID: 22032647 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of urine cytology in detecting histologic variants of urothelial carcinomas in the urinary bladder: Cytopathologic correlation of 72 cases. Yoo Y; Choi E; Lee DH; Park S; Sung SH Diagn Cytopathol; 2021 Mar; 49(3):367-373. PubMed ID: 33331144 [TBL] [Abstract][Full Text] [Related]
14. Usefulness of NMP22 as an adjunct to a typical urine cytology and low-grade urothelial carcinoma. Arora VK; Sarungbam J; Bhatia A; Singh N; Agrawal V; Aggarwal S Diagn Cytopathol; 2010 Nov; 38(11):788-90. PubMed ID: 20014314 [TBL] [Abstract][Full Text] [Related]
15. Fluorescence in situ hybridization (FISH) in the diagnosis of bladder and upper tract urothelial carcinoma: the largest single-institution experience to date. Gomella LG; Mann MJ; Cleary RC; Hubosky SG; Bagley DH; Thumar AB; McCue PA; Lallas CD; Trabulsi EJ Can J Urol; 2017 Feb; 24(1):8620-8626. PubMed ID: 28263126 [TBL] [Abstract][Full Text] [Related]
16. Diagnosis of urinary bladder urothelial carcinoma by immunocytology with p53, MCM5, MCM2 and Ki-67 antibodies using cell blocks derived from urine. Brisuda A; Háček J; Čechová M; Škapa P; Babjuk M Cytopathology; 2019 Sep; 30(5):510-518. PubMed ID: 30943322 [TBL] [Abstract][Full Text] [Related]
18. The effects of the current World Health Organization/International Society of Urologic Pathologists bladder neoplasm classification system on urine cytology results. Curry JL; Wojcik EM Cancer; 2002 Jun; 96(3):140-5. PubMed ID: 12115301 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma. Veeramachaneni R; Nordberg ML; Shi R; Herrera GA; Turbat-Herrera EA Diagn Cytopathol; 2003 Jun; 28(6):301-7. PubMed ID: 12768634 [TBL] [Abstract][Full Text] [Related]
20. Comparison of urine cytology diagnostic reports before and after the implementation of the Paris System classification system in China. Ma C; Zhang L Cytopathology; 2020 Sep; 31(5):457-462. PubMed ID: 32246545 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]